2229779
Cooperative Agreement
Overview
Grant Description
SBIR Phase II: Final Ink and Stamp Development and Safety Testing for the SPF Indicator Stamp - The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to help reduce sunburn (a primary risk factor for melanoma), skin cancer, and photoaging rates by helping people to apply and reapply adequate amounts of sunscreen.
Sunburns, 93% of skin cancer, and up to 90% of the age-related changes to skin are caused by overexposure to ultraviolet radiation (UVR). Skin cancer is more commonly diagnosed than all other forms of cancer combined in the U.S., with estimated annual treatment costs of $8.1 billion. Sunscreen is an over-the-counter drug that can prevent the damaging effects of UVR, yet multiple studies show that sunscreen users only apply about a third of the recommended amount of sunscreen and do not reapply often enough.
The recreational (beach and body) sunscreen market is $2.5 billion in the U.S. ($11 billion globally) and growing at an annual rate of 7%. By helping people apply and reapply the correct amount of sunscreen at the right time, this project will help prevent sunburns, skin cancer, and photoaging.
This Small Business Innovation Research (SBIR) Phase II project will result in the first accurate, affordable, and convenient sunscreen effectiveness indicator. Though other photochromic (UV-sensitive and color-changing) sunscreen effectiveness indicators exist in the marketplace, they are inaccurate (temperature and UVA1 sensitivities cause reporting errors), expensive (>$0.60 per use), and inconvenient (stickers and wristband formats), which largely account for their lack of market adoption.
This project will result in the first stamp-on-skin photochromic sunscreen effectiveness indicator in two formats: a stand-alone stamp that will work with any sunscreen and a stamp-in-cap format that is built into the sunscreen's cap. It will also result in two different photochromic ink formulations (one for use with sunscreen lotions and another for sunscreen sprays) which will be stamped onto users' skin and accurately report - at-a-glance and in real-time - the degree of users' sun protection so they can apply and reapply the right amount of sunscreen at the right time.
A single stamp will last an entire day in wet or dry conditions and withstand multiple color-fade and sunscreen reapplication cycles. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Sunburns, 93% of skin cancer, and up to 90% of the age-related changes to skin are caused by overexposure to ultraviolet radiation (UVR). Skin cancer is more commonly diagnosed than all other forms of cancer combined in the U.S., with estimated annual treatment costs of $8.1 billion. Sunscreen is an over-the-counter drug that can prevent the damaging effects of UVR, yet multiple studies show that sunscreen users only apply about a third of the recommended amount of sunscreen and do not reapply often enough.
The recreational (beach and body) sunscreen market is $2.5 billion in the U.S. ($11 billion globally) and growing at an annual rate of 7%. By helping people apply and reapply the correct amount of sunscreen at the right time, this project will help prevent sunburns, skin cancer, and photoaging.
This Small Business Innovation Research (SBIR) Phase II project will result in the first accurate, affordable, and convenient sunscreen effectiveness indicator. Though other photochromic (UV-sensitive and color-changing) sunscreen effectiveness indicators exist in the marketplace, they are inaccurate (temperature and UVA1 sensitivities cause reporting errors), expensive (>$0.60 per use), and inconvenient (stickers and wristband formats), which largely account for their lack of market adoption.
This project will result in the first stamp-on-skin photochromic sunscreen effectiveness indicator in two formats: a stand-alone stamp that will work with any sunscreen and a stamp-in-cap format that is built into the sunscreen's cap. It will also result in two different photochromic ink formulations (one for use with sunscreen lotions and another for sunscreen sprays) which will be stamped onto users' skin and accurately report - at-a-glance and in real-time - the degree of users' sun protection so they can apply and reapply the right amount of sunscreen at the right time.
A single stamp will last an entire day in wet or dry conditions and withstand multiple color-fade and sunscreen reapplication cycles. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Awardee
Funding Goals
THE GOAL OF THIS FUNDING OPPORTUNITY, "NSF SMALL BUSINESS INNOVATION RESEARCH PHASE II (SBIR)/ SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS PHASE II", IS IDENTIFIED IN THE LINK: HTTPS://WWW.NSF.GOV/PUBLICATIONS/PUB_SUMM.JSP?ODS_KEY=NSF22552
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Seattle,
Washington
98195-2141
United States
Geographic Scope
Single Zip Code
Related Opportunity
22-552
Analysis Notes
Amendment Since initial award the End Date has been extended from 12/31/24 to 06/30/26 and the total obligations have decreased 40% from $1,998,854 to $1,199,310.
Sunfly Brands was awarded
Cooperative Agreement 2229779
worth $1,199,310
from National Science Foundation in April 2023 with work to be completed primarily in Seattle Washington United States.
The grant
has a duration of 3 years 2 months and
was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships.
SBIR Details
Research Type
SBIR Phase II
Title
SBIR Phase II:Final Ink and Stamp Development and Safety Testing For the SPF Indicator Stamp
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to help reduce sunburn (a primary risk factor for melanoma), skin cancer, and photoaging rates by helping people to apply and reapply adequate amounts of sunscreen.Sunburns, 93% of skin cancer, and up to 90% of the age-related changes to skin are caused by overexposure to ultraviolet radiation (UVR). Skin cancer is more commonly diagnosed than all other forms of cancer combined in the U.S. with estimated annual treatment costs of $8.1 billion. Sunscreen is an over-the-counter drug that can prevent the damaging effects of UVR, yet multiple studies show that sunscreen users only apply about a third of the recommended amount of sunscreen and do not reapply often enough. The recreational (beach and body) sunscreen market is $2.5 billion in the U.S. ($11 billion globally) and growing at an annual rate of 7%.By helping people apply and reapply the correct amount of sunscreen at the right time, this project will help prevent sunburns, skin cancer, and photoaging._x000D_
_x000D_
This Small Business Innovation Research (SBIR) Phase II project will result in the first accurate, affordable, and convenient sunscreen effectiveness indicator. Though other photochromic (UV-sensitive and color-changing) sunscreen effectiveness indicators exist in the marketplace, they are inaccurate (temperature and UVA1 sensitivities cause reporting errors), expensive (greater than$0.60 per use) and inconvenient (stickers and wristband formats) which largely account for their lack of market adoption. This project will result in the first stamp-on-skin photochromic sunscreen effectiveness indicator in two formats: a stand-alone stamp that will work with any sunscreen and a stamp-in-cap format that is built into the sunscreen’s cap. It will also result in two different photochromic ink formulations (one for use with sunscreen lotions and another for sunscreen sprays) which will be stamped onto user’s skin and accurately report—at-a-glance and in real-time the degree of users’ sun protection so they can apply and reapply the right amount of sunscreen at the right time.A single stamp will last an entire day in wet or dry conditions and withstand multiple color-fade and sunscreen reapplication cycles._x000D_
_x000D_
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Topic Code
BM
Solicitation Number
NSF 22-552
Status
(Ongoing)
Last Modified 4/4/25
Period of Performance
4/1/23
Start Date
6/30/26
End Date
Funding Split
$1.2M
Federal Obligation
$0.0
Non-Federal Obligation
$1.2M
Total Obligated
Activity Timeline
Transaction History
Modifications to 2229779
Additional Detail
Award ID FAIN
2229779
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
Small Business
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
DDM5KGX5TQA5
Awardee CAGE
8CT23
Performance District
WA-07
Senators
Maria Cantwell
Patty Murray
Patty Murray
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Research and Related Activities, National Science Foundation (049-0100) | General science and basic research | Grants, subsidies, and contributions (41.0) | $999,427 | 100% |
Modified: 4/4/25